Lisata Therapeutics
LSTA
34 hedge funds and large institutions have $5.27M invested in Lisata Therapeutics in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
288% more capital invested
Capital invested by funds: $1.36M → $5.27M (+$3.91M)
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
36% more funds holding
Funds holding: 25 → 34 (+9)
3.6% more ownership
Funds ownership: 8.11% → 11.71% (+3.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DAM
Deltec Asset Management
New York
|
+$372K |
| 2 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
+$310K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$256K |
| 4 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$196K |
| 5 |
VF
Virtu Financial
New York
|
+$174K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$136K |
| 2 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$72.5K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$26.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.29K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$268 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
26
Connective Capital Management
Palo Alto,
California
| $5.09K | – | – | – |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $3.93K | -$7.29K | -1,767 | -69% |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $1K | +$413 | +100 | +100% |
|
29
Morgan Stanley
New York
| $376 | – | – | – |
|
|
CIAM
30
Caitong International Asset Management
Hong Kong
| $110 | +$91 | +22 | New |
|
|
SS
31
SBI Securities
Tokyo,
Japan
| $35 | – | – | – |
|
|
CVM
32
Cheviot Value Management
Beverly Hills,
California
| $15 | – | – | – |
|
33
Citigroup
New York
| $5 | – | – | – |
|
|
FFO
34
Fortitude Family Office
Scottsdale,
Arizona
| $5 | – | – | – |
|
|
BCM
35
BML Capital Management
Zionsville,
Indiana
| – | -$136K | -73,348 | Closed |
|
|
GSC
36
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$72.5K | -38,987 | Closed |
|
|
37
Dimensional Fund Advisors
Austin,
Texas
| – | -$26.5K | -14,253 | Closed |
|
|
NA
38
NewEdge Advisors
New Orleans,
Louisiana
| – | -$199 | -107 | Closed |
|
LSTA Hedge Fund Activity: Q1 2026 in Review
34 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q1 2026, worth a combined $5.27M — up 288% from $1.36M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new LSTA positions and 4 closed out — a net gain of 10 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Deltec Asset Management, opening a new position worth an estimated $372K. The largest seller was BML Capital Management, exiting entirely with an estimated $136K sold.
- 34 institutional investors held Lisata Therapeutics (LSTA) as of Q1 2026, up from 25 in Q4 2025.
- Funds reported $5.27M of Lisata Therapeutics stock for Q1 2026, up 288% quarter-over-quarter.
- 14 funds opened new Lisata Therapeutics positions in Q1 2026 and 4 closed out, a net change of +10 holders.
- The largest Lisata Therapeutics buyer in Q1 2026 was Deltec Asset Management, an estimated $372K added.
- The largest Lisata Therapeutics seller in Q1 2026 was BML Capital Management, an estimated $136K sold.
Based on aggregated 13F filings for Q1 2026.